Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: J Orthop Res. 2019 Nov 17;38(4):811–822. doi: 10.1002/jor.24516

The MRL/MpJ Mouse Strain Is Not Protected From Muscle Atrophy And Weakness After Rotator Cuff Tear

Jeffrey R Talarek 1, Alex N Piacentini 1, Alexis C Konja 1, Susumu Wada 1, Jacob B Swanson 1, Samuel C Nussenzweig 1, Joshua S Dines 1,2, Scott A Rodeo 1,2, Christopher L Mendias 1,2,3,*
PMCID: PMC7071998  NIHMSID: NIHMS1061768  PMID: 31696955

Abstract

Chronic rotator cuff tears are a common source of shoulder pain and disability. Patients with rotator cuff tears often have substantial weakness, fibrosis, and fat accumulation which limit successful surgical repair and postoperative rehabilitation. The Murphy Roths Large (MRL) strain of mice have demonstrated superior healing and protection against pathological changes in several disease and injury conditions. We tested the hypothesis that, compared to the commonly used C57Bl/6 (B6) strain, MRL mice would have less muscle fiber atrophy and fat accumulation, and be protected against the loss in force production that occurs after cuff tear. Adult male B6 and MRL mice were subjected to a rotator cuff tear, and changes in muscle fiber contractility and histology were measured. RNA sequencing, and shotgun metabolomics and lipidomics were also performed. Muscles were harvested one month after tear. B6 and MRL mice had a 40% reduction in relative muscle force production after rotator cuff tear. RNA sequencing identified an increase in fibrosis-associated genes and a reduction in mitochondrial metabolism genes. Markers of glycolytic metabolism increased in B6 mice, while MRL mice appeared to increase amino acid metabolism after tear. There was an accumulation of lipid after injury, although there was a divergent response between B6 and MRL mice in the types of lipid species that accrued. There were strain-specific differences between the transcriptome, metabolome, and lipidome of B6 and MRL mice, but these differences did not protect MRL mice from weakness and pathological changes after rotator cuff tear.

Keywords: muscle atrophy, myosteatosis, tenotomy, metabolomics, lipidomics

Introduction

Rotator cuff tears are among the most frequent upper extremity injuries, with over 250,000 surgical repairs performed annually in the US 1. Although patients generally experience pain relief after rotator cuff repair, many remain unsatisfied with persistent muscle weakness 2. The strength deficits that patients experience are due to the pathological changes that occur in torn rotator cuff muscles, including fibrosis, muscle fiber atrophy, and fat accumulation in and around muscle fibers 3–5. These combined pathological changes, often referred to as fatty degeneration or myosteatosis, limit successful surgical repair and prevent the restoration of strength through postoperative rehabilitation 3,6,7. Gaining a greater understanding of the biological mechanisms that lead to fatty degeneration could identify novel therapies to improve clinical outcomes for patients with chronic cuff tears.

The Murphy Roths Large (MRL/MpJ, or MRL) line of mice have received attention as a “super healing” strain with enhanced tissue regeneration compared to many standard mouse strains 8. MRL mice have an absence of articular cartilage degeneration and improved regeneration and after joint injury 9,10, and superior mechanical properties and healing after tendon injury 11,12. MRL mice also display reduced muscle fibrosis in a γ-sarcoglycan-deficient model of muscular dystrophy 13, and muscle progenitor cells from MRL mice display increased rates of proliferation and myogenesis in vitro 14,15. However, the MRL strain does not display enhanced tissue healing for every organ system and type of injury, with no differences noted between MRL mice and controls in dorsal skin healing following punch injury, nor in cardiac healing following infarct 16,17.

While there are previous findings that suggest that MRL mice might be protected against atrophy in the context of a rotator cuff tear, the rotator cuff demonstrates more pronounced degeneration after tendon rupture than other muscle groups 18, and there is a reduced myogenic capacity of satellite cells from the rotator cuff compared to satellite cells from other limb muscles 19. Given the context-dependent differences in tissue healing in MRL mice, we sought to evaluate the pathological changes that occur in MRL mice following a rotator cuff tear. Based on the improvement in healing in other musculoskeletal injury and disease models, we hypothesized that MRL mice would display less muscle fiber atrophy and fat accumulation, and experience less of a loss in strength, than C57Bl/6 (B6) mice. To test this hypothesis we performed a full-thickness supraspinatus and infraspinatus tenectomy and denervation in adult male MRL and B6 mice, and measured muscle fiber contractility and histology. We also performed RNA sequencing (RNAseq) and mass spectrometry-based muscle metabolomics and lipidomics to further explore biological differences between B6 and MRL mice after a rotator cuff tear and identify any potential mechanistic differences that could translate to a potential therapy for fatty degeneration.

Methods

Animals

This study was approved by the Hospital for Special Surgery IACUC (protocol 2017–0035). All experiments were performed in accordance with the approved protocol. Three-month old male C57Bl/6J (B6, strain 000664, Jackson Labs, Bar Harbor, ME) and MRL/MpJ (MRL, strain 000486, Jackson Labs) were used. Mice were housed under specific pathogen free conditions and allowed ad libidum access to food and water, but were fasted for four hours prior to harvest to minimize any impacts of acute food consumption on metabolite measurements. A total of N=20 mice were used in the study, with N=4 control B6 mice, N=4 control MRL mice, N=6 surgical B6 mice, and N=6 surgical MRL mice.

Surgical Model

Mice were anesthetized with 2% isoflurane, and a bilateral, full-thickness supraspinatus and infraspinatus tenectomy and denervation was performed 20,21. A deltoid-splitting transacromial approach exposed the supraspinatus and infraspinatus tendons which were then finely detached from their humeral footprint. Tendons were also transected just distal to the myotendinous junction, allowing for removal of the tendon and to prevent spontaneous reattachment of the tendon to the surrounding fascia 22,23. An approximately 3mm segment of the suprascapular nerve was removed to denervate the muscles. Denervation was performed as patients with rotator cuff tears demonstrate signs of muscle fiber denervation 24. The incision was closed and mice were treated with buprenorphine twice post-operatively (0.05mg/kg, Reckitt, Parsippany, NJ).

After 30 days, mice were anesthetized with 2% isoflurane, and supraspinatus and infraspinatus muscles were harvested and weighed. The left supraspinatus was prepared for muscle fiber contractility measurements. The right supraspinatus was mounted on a cork disk with tragacanth gum, snap frozen in isopentane and stored at −80°C for histology. The left infraspinatus was finely minced and snap frozen in liquid nitrogen and stored at −80°C for metabolomics and lipidomics studies. The right infraspinatus was snap frozen and stored at −80°C for RNA isolation. Soleus muscles were also harvested to verify fiber type analysis. Animals were humanely euthanized by cervical dislocation.

Muscle Fiber Contractility

Permeabilized muscle fiber contractility was performed as described 20,25. Small bundles of fibers were dissected free of the muscle, chemically permeabilized, and stored at −80°C. Individual fibers were placed in a chamber containing relaxing solution and secured at one end to a servomotor (Aurora Scientific, Aurora, ON) and the other end to a force transducer (Aurora Scientific) using 10–0 monofilament nylon suture. Using a video sarcomere length measurement system (Aurora Scientific), fiber length was adjusted to obtain a sarcomere length of 2.5μm. The average fiber CSA was calculated assuming the fiber had an elliptical cross-section, with diameters obtained at five positions along the length of the fiber from top and side views. Maximum isometric force (Fo) was measured by immersing the fiber in a high calcium activation solution, and specific maximum isometric force (sFo) was determined by dividing Fo by fiber CSA. Eight to ten fibers were tested from each muscle. Due to the nature of the permeabilization process, fibers swell in proportion to their CSA 26, and therefore CSA values of permeabilized fibers are greater than measurements from histology.

Histology

Histology was performed as described 27,28. Sections were blocked with a MOM Blocking Kit (Vector Labs, Burlingame, CA) and incubated with primary antibodies from Developmental Studies Hybridoma Bank (Iowa City, IA) against type I myosin heavy chain (MHC) (BA-D5), type IIA MHC (SC-71), and type IIB MHC (BF-F3). Type IIX MHC was identified by the lack of signal. Secondary antibodies conjugated to AlexaFluor 350, 488, or 555 (Thermo Fisher Scientific, Waltham, MA) detected primary antibodies. Glycosaminoglycans (GAGs) in the extracellular matrix (ECM) were detected using wheat germ agglutinin (WGA) conjugated to AlexaFluor 647. Digital images of slides were captured using an EVOS FL microscope (Thermo Scientific). CSAs of muscle fibers were measured with ImageJ (NIH, Bethesda, MD).

Gene Expression and RNA Sequencing

RNA was isolated from muscles, and gene expression and RNA sequencing (RNAseq) was performed as described 20. Samples were homogenized in QIAzol (Qiagen, Valencia, CA) and RNA was isolated using 5PRIME Phase Lock Gel tubes (Quantabio, Beverly, MA), an RNeasy Mini kit (Qiagen), and DNase I (Qiagen). RNA concentration and quality were assessed using a NanoDrop One (Thermo Fisher Scientific) and a BioAnalyzer 2100 (Agilent, Santa Clara, CA). All samples had RIN values > 8.1.

A total of 250ng of RNA was delivered to the Weill Cornell Epigenomics Core for processing and sequencing. cDNA pools were created for each sample, and then subsequently tagged with a barcoded oligo adapter. Sequencing occurred in an Illumina HiSeq 2500 system (Illumina, San Diego, CA) with 50bp single end reads. Data quality was checked using FastQC, and aligned to the reference genome (mm10, UCSC, Santa Cruz, CA). Differential expression was calculated using edgeR 29. Complete RNAseq data is available through NIH GEO (ascension number GSE130447).

For quantitative PCR (qPCR), RNA was reverse transcribed into cDNA using iScript Supermix (Bio-Rad). cDNA was amplified in a CFX96 real-time thermal cycler (Bio-Rad) using SsoFast SYBR Green Supermix (Bio-Rad). Target gene expression was normalized to the housekeeping gene casein kinase 2α1 (Csnk2a1) using the 2−ΔCt method.

Biological Pathway Analysis

Expression data from RNAseq was analyzed with Ingenuity Pathway Analysis (IPA) software (Qiagen) to assist in predicting cellular and molecular pathways that were different between groups.

Metabolomics and Lipidomics

Mass spectrometry-based metabolomics and lipidomics was performed by the University of Michigan Metabolomics Core as described 20,30. Summary data is provided in the manuscript, with complete data available in Supplemental Tables S1 and S2. Metabolites were extracted from frozen muscle, derivatized, and analyzed with gas chromatography-MS 31. Quantification of metabolites was performed using Masshunter Quantitative Analysis software (Agilent Technologies, Santa Clara, CA, USA). Two samples from the B6 tear group failed quality control and were excluded from analysis.

Lipids were extracted from samples and subjected to liquid chromatrography-mass spectrometry (LC-MS). MS peaks were matched in-silico with LipidBlast 32. Quantification was performed by Multiquant software (AB-SCIEX, Framingham, MA). One WT sample failed quality control and was excluded from analysis. MetaboAnalyst 4.0 33 performed principal component (PC) analyses.

Statistics

Values are presented as mean±SD. Differences between groups were determined using a two-way ANOVA (α=0.05) followed by Fisher’s LSD post-hoc sorting. Differences in fiber type distribution were assessed with a χ2 test. For RNAseq, metabolomics, and lipidomics, a false discovery rate correction was used to adjust p-values for multiple observations, and are reported as q-values. With the exception of RNAseq analyses performed with edgeR, calculations were performed in Prism software (version 8, GraphPad, San Diego, CA).

Results

Following rotator cuff tear, the body weight normalized supraspinatus muscle mass of B6 mice was reduced by nearly 50%, while MRL mice displayed a 42% reduction (Table 1). Infraspinatus muscles demonstrated a similar trend (Table 1). Neither strain lost body mass after cuff tear, although the MRL mice were 55% larger than B6 mice at baseline (Table 1).

Table 1.

Body and muscle mass data.

B6 MRL
Control
Tear
Control
Tear
Body mass (g) 30.4±1.8 27.1±1.2 47.2±1.6a,b 47.1±2.5a,b
Supraspinatus mass (mg) 37.1±1.5 17.1±2.2a 54.3±3.5a,b 31.4±2.6a,b,c
Supraspinatus/body mass (mg/g) 1.22±0.08 0.62±0.07a 1.15±0.04b 0.67±0.05a,c
Infraspinatus mass (mg) 33.0±4.2 16.8±1.8a 50.3±6.2a,b 30.9±2.5b,c
Infraspinatus/body mass (mg/g) 1.08±0.10 0.61±0.07a 1.06±0.10b 0.66±0.07a,c

Values are mean±SD. Differences between groups assessed using a two-way ANOVA.

Posthoc sorting

a

different (p<0.05) from B6 control

b

different (p<0.05) from B6 tear

c

different (p<0.05) from MRL control.

N≥4 mice per group.

To assess functional changes in muscles after injury, we measured permeabilized muscle fiber contractility. No changes in permeabilized fiber CSA were noted (Figure 1A). Fo of control MRL mice was 44% larger than control B6 mice, and after tear Fo was reduced in B6 mice by 46% and by 50% in MRL mice (Figure 1B). sFo was 52% higher in control MRL mice than B6 mice, and both groups were reduced by 40% after tear (Figure 1C).

Figure 1. Muscle Fiber Contractility.

Figure 1.

(A) Permeabilized muscle fiber cross-sectional area (CSA), (B) maximum isometric force (Fo), and (C) specific maximum isometric force (sFo) of supraspinatus muscles. Black, B6 control (Ctrl); dark gray, B6 tear; light gray, MRL ctrl; white, MRL tear. Differences between groups assessed using a two-way ANOVA. Posthoc sorting: a, different (p<0.05) from B6 control; b, different (P<0.05) from B6 tear; c, different (p<0.05) from MRL control. N≥4 muscles per group.

For histology, we detected type IIA, IIB, IIX, IIA/IIX, and IIB/IIX fibers in rotator cuff muscles, but did not observe type I fibers (Figure 2A). Soleus muscles of B6 mice, which are known to contain type I fibers, served as positive controls (Figure 2A). There was a significant difference in the distribution of fiber types between B6 control tear muscles, MRL control and tear muscles, and B6 tear and MRL tear muscles, but no difference in distribution between B6 control and MRL control muscles (Figure 2B). The most abundant fiber type in all conditions were type IIB fibers. However, for B6 mice the percentage of IIB fibers went from 58% to 45%, and IIX fibers increased in proportion from 27% to 35% after tear (Figure 2B). In MRL mice, IIB fibers dropped from 50% to 36%, and the largest increase in fiber type was type IIA, going from 8% to 17% after tear (Figure 2B). Both strains lost fibers after tear, with B6 and MRL mice losing 36% and 50% of fibers per supraspinatus, respectively (Figure 2C). The type IIB and IIX fibers of control MRL mice were 41% and 74% larger than B6, respectively (Figure 2D). After injury, the size of type IIB fibers was reduced by 38% in B6 mice and by 45% in MRL mice (Figure 2D).

Figure 2. Fiber Type Histology.

Figure 2.

(A) Representative fiber type immunofluorescence labeling of supraspinatus muscles. A soleus muscle is shown as a control. Blue, myosin heavy chain (MHC) I; red, MHC IIA; green, MHC IIB; black (lack of signal), MHC IIX; glycosaminoglycans (GAG), teal. Scale bar for supraspinatus is 50μm and for soleus is 25μm. (B) Percent distribution by fiber type and chi-squared analysis. (C) Number of fibers per histology cross-section, and (D) cross-sectional area (CSA) of fibers by fiber type. Black, B6 control (Ctrl); dark gray, B6 tear; light gray, MRL ctrl; white, MRL tear. Differences between groups assessed using (B) a chi-squared test or (C-D) a two-way ANOVA. Posthoc sorting (C-D): a, different (p<0.05) from B6 control; b, different (p<0.05) from B6 tear; c, different (p<0.05) from MRL control. N≥4 muscles per group.

To identify global changes in the transcriptome of muscles, we performed RNAseq. We used IPA for pathway enrichment analysis and to identify genes that were important in the response to rotator cuff tear within and between strains (Table 2). To allow for detailed exploratory analysis, RNAseq is presented in two Figures. Figure 3 presents the differences between B6 tear to control, MRL tear to control groups, and individual genes are graphed based on known roles in fatty degeneration, and those identified from IPA analysis. Figure 4 shows the differences between B6 control to MRL control, B6 tear to MRL tear, and the top 30 genes that were upregulated and downregulated across strains and conditions.

Table 2.

Gene enrichment analysis.

Pathway B6 Ctrl to B6 Tear MRL Ctrl to MRL Tear B6 Ctrl to MRL Ctrl B6 Tear to MRL Tear

Actin Cytoskeleton Signaling 5.4E–06 5.6E–07 ND 4.4E–02
Axonal Guidance Signaling 2.5E–12 7.9E–17 ND 2.4E–02
Death Receptor Signaling 1.1E–05 1.2E–09 6.0E–03 3.0E–02
EIF2 Signaling 3.9E–09 3.3E–04 2.3E–02 6.5E–04
ERK/MAPK Signaling 2.2E–04 2.3E–06 ND ND
FAK Signaling 2.6E–04 2.0E–04 ND ND
IGF1 Signaling 5.4E–08 9.1E–06 ND 4.7E–03
Integrin Signaling 1.0E–08 2.1E–10 ND 1.9E–02
JAK/Stat Signaling 1.6E–04 5.4E–04 ND 2.5E–04
Mitochondrial Dysfunction 5.0E–11 1.5E–03 ND ND
mTOR Signaling 1.7E–08 7.6E–05 ND ND
p38 MAPK Signaling 3.2E–04 1.8E–03 ND ND
p70S6K Signaling 3.1E–06 2.3E–08 ND 7.2E–03
PDGF Signaling 3.7E–04 1.1E–05 ND 4.6E–04
Phospholipase C Signaling 2.3E–08 5.0E–12 4.7E–02 ND
Phospholipases 2.9E–02 6.6E–03 1.3E–02 1.9E–02
RhoA Signaling 2.5E–10 4.7E–10 ND 4.9E–02
STAT3 Pathway 3.6E–07 1.2E–06 ND 4.8E–04
TGFβ Signaling 4.7E–05 1.4E–04 ND 1.1E–03

The q-values of selected differentially regulated pathways that were identified using Ingenuity Pathway Analysis.

ND, not significantly different.

Figure 3. RNA Sequencing Comparing B6 Tear to MRL Control and MRL Tear to MRL Control.

Figure 3.

Volcano plot of transcripts that were differentially regulated between (A) B6 tear and control (ctrl) groups, and (B) MRL tear and ctrl groups. Heatmaps demonstrating the log2-fold change in tears to controls for both B6 and MRL mice for transcripts related to (C) hypertrophy and atrophy, (D) muscle fiber contractility and cytoskeletal organization, (E) extracellular matrix, (F) growth factors, cytokines, and receptors, and (G) metabolism. #, different (q<0.05) between ctrl and tear groups within a strain; †, different (q<0.05) between B6 ctrl and MRL ctrl groups; *, different (q<0.05) between B6 tear and MRL tear groups. N=4 infraspinatus muscles per group.

Figure 4. RNA Sequencing Comparing B6 Control to MRL Control and B6 Tear to MRL Tear.

Figure 4.

(A) Volcano plot of differentially regulated transcripts, and the top 30 (B) upregulated and (C) downregulated transcripts of B6 control and MRL control groups. (D) Volcano plot of differentially regulated transcripts, and the top 30 (E) upregulated and (F) downregulated transcripts of B6 tear and MRL tear groups. Data is expressed as log2-fold change of MRL groups normalized to B6 groups. *, different (q<0.05) between B6 tear and MRL tear groups. N=4 infraspinatus samples per group.

There were 2793 transcripts significantly upregulated by 50% in B6 tear muscles compared to B6 controls, and 2367 significantly downregulated by 50% (Figure 3A). In MRL mice, there were 2493 transcripts significantly upregulated by 50% and 1692 transcripts downregulated by 50% in tear groups compared to controls (Figure 3B). For muscle fiber hypertrophy and atrophy, genes involved with translation like Eef1a1, Eif4a1, Rpl14, Rpl26, and Rpsa were upregulated in both strains after tear, as were the proteolytic genes Capn2 and Nedd8, while other genes involved with protein degradation and autophagy like Atg14, Fbxo32, Nedd4, Pik3c3, and Ulk1 were downregulated (Figure 3C). Contractility and cytoskeletal organization genes were generally downregulated in B6 and MRL mice after tear, including Acta1, Actn3, Dag1, Dmd, Dtna, Mypbc2, Myh4, Nf2, and Nos1, while Actn1, Msn, and Myog were upregulated, and Myh8 was down in B6 mice and upregulated in MRL mice (Figure 3D). ECM genes were nearly all upregulated in both strains after rotator cuff tear, including Bgn, Col1a1, Col4a1, Col14a1, Eln, Lox, Loxl1, Mmp2, Mmp13, Mmp14, Thsb4, Timp1, Tnmd, and Tnc, as were the fibroblast markers S100a4, Scx, and Tcf7l2 (Figure 3E). Several growth factors and signaling molecules were also induced in B6 and MRL mice after tear, such as Bmp1, Bmp6, Ctgf, Igf1, Pdgfb, and Tgfb1, while Fgf2, Mstn, and Wnt4 were downregulated (Figure 3F). No differences in the transcription factor Hif1a were observed (Figure 3F). Macrophage cell markers and recruitment genes like Cd68 and Cxcl12 were induced (Figure 3F). The muscle innervation marker Kcnj12 was downregulated, and the denervation marker Ncam was upregulated (Figure 3F). Metabolic genes generally showed a downregulation in both strains after rotator cuff tear, including glycolytic genes such as Eno3, Fbp2, Hk2, as well mitochondrial and oxidative phosphorylation genes like Acads, Acss1, Cpt1b, Cpt2, Sdha, Slc25a20, and Suclg1 (Figure 3G).

Comparing MRL control to B6 control, 408 transcripts were upregulated by at least 50% and 429 were downregulated by at least 50% (Figure 4A). For tear groups, 497 transcripts were at least 50% upregulated in MRL mice and 402 were downregulated by the same extent (Figure 4D). Many of the genes that were most highly differentially expressed between the strains, either in control or tear groups, are pseudogenes or unannotated transcripts (Figure 4B–C,E–F). Rotator cuff tear did not affect the expression of many of the most highly differentially expressed genes between strains (Figure 4B–C,E–F). Changes in genes evaluated using RNAseq generally matched observations from qPCR (Supplemental Table S3).

We then sought to explore the effect of rotator cuff tear on the metabolome. PC analysis demonstrated moderate overlap between groups (Figure 5A). For amino acids, arginine, asparagine, aspartate, glutamine, histidine, ornithine, serine, tyrosine, and valine were greater in MRL mice after rotator cuff tear but not in B6 mice, while lysine, phenylalanine, and tryptophan were elevated in both strains (Figure 5B). Some glycolytic metabolites were induced, with B6 tear mice uniquely demonstrating elevations in 2-phosphoglycerate/3-phosphoglycerate (2PG/3PG), 6-phosphoglycerate (6PG), erythrose 4-phosphate (E4P), fructose-6-phosphate/glucose-6-phosphate (F6P/G6P), phosphoenolpyruvate (PEP), and ribulose 5-phosphate and xylulose 5-phosphate (R5P/X5P), while acetyl-phosphate (acetyl-P), gluconate, and hexoses were greater in MRL mice (Figure 5C). Creatine, creatinine, and lactate were significantly lower in MRL mice after rotator cuff tear, but not B6 (Figure 5C). Krebs cycle intermediates acetyl Co-A and malate were enriched in B6 mice, while succinate was lower (Figure 5D). Reduced glutathione (GSH), oxidized glutathione (GSSG), and pantothenate were lower in MRL mice after tear (Figure 5D). The nucleotide and nucleoside metabolites AMP, ATP, GDP, GMP, hypoxanthine, and uridine diphosphate-N-acetyl-D-glucosamine (UDP-N-A-D-G) were higher in B6 mice, while GTP, inosine, UDP, and xanthine were uniquely elevated in MRL mice (Figure 5E). CMP, IMP, UMP, and UTP were reduced in MRL mice, and uridine diphosphate-D-glucose (UDP-D-Gluc) was lower in both strains after rotator cuff tear (Figure 5E).

Figure 5. Metabolomics.

Figure 5.

(A) Principal component (PC) analysis of infraspinatus muscles. Red, B6 control; green, B6 tear; blue, MRL control; yellow, MRL tear. Heatmaps demonstrating the log2-fold change of tear groups to controls for both B6 and MRL mice for metabolites related to (B) amino acid, (C) glycolytic, (D) Krebs cycle, and (E) nucleotide and nucleoside metabolism. Differences between groups assessed using false discovery rate corrected t-tests. #, different (q<0.05) between ctrl and tear groups within a strain; †, different (q<0.05) between B6 ctrl and MRL ctrl groups; *, different (q<0.05) between B6 tear and MRL tear groups. N=4 infraspinatus muscles per group except MRL tear which has N=6. Abbreviations: 2PG/3PG, 2-phosphoglycerate and 3-phosphoglycerate; 6PG, 6-phosphoglycerate; CIT/ICIT, citrate and isocitrate; E4P, erythrose 4-phosphate; F6P/G6P, fructose-6-phosphate and glucose-6-phosphate; FBP, fructose bisphosphate; Glycerol-3-P, glycerol-3-phosphate; GSH, reduced glutathione; GSSG, oxidized glutathione; N-Acetyl-G-1-P, N-acetyl-glucosamine-1-phosphate; PEP, phosphoenolpyruvate; R5P/X5P, ribulose 5-phosphate and xylulose 5-phosphate; S7P, sedoheptulose 7-phosphate; UDP-D-Gluc, uridine diphosphate-D-glucose; UDP-D-Glucu, uridine diphosphate-D-glucuronate; and UDP-N-A-D-G, uridine diphosphate-N-acetyl-D-glucosamine.

Finally, we evaluated the lipidome after cuff tear. The PC analysis demonstrated a fair amount of overlap between tear groups, and some divergence in control groups (Figure 6A). The uniquely induced species for B6 mice after tear included cholesterol esters (CE), glucosylceramides (GlcCer), lysophosphatidylethanolamines (LysoPE), and triglycerides (TG), while MRL mice had elevations in free fatty acids (FFA), phosphatidylcholines (PC), phosphatidylethanolamines (PE), and plasmenyl phosphatidylethanolamines (PlasmenylPE) (Figure 6B). Lysophosphatidylcholines (LysoPC), monoglycerides, and sphingomyelins were induced in both groups (Figure 6B).

Figure 6. Lipidomics.

Figure 6.

(A) Principal component (PC) analysis of infraspinatus muscles. Red, B6 control; green, B6 tear; blue, MRL control; yellow, MRL tear. Heatmaps demonstrating the log2-fold change of tear groups to controls for both B6 and MRL mice for lipid species. Differences between groups assessed using false discovery rate corrected t-tests. #, different (q<0.05) between ctrl and tear groups within a strain; †, different (q<0.05) between B6 ctrl and MRL ctrl groups; *, different (q<0.05) between B6 tear and MRL tear groups. N=4 infraspinatus muscles per group for control samples and N=6 infraspinatus muscles per group for tear samples. Abbreviations: BMP, bis(monoacylglycero)phosphates; CE, cholesterol esters; FFA, free fatty acids; GlcCer, glucosylceramides; LysoPC, lysophosphatidylcholines; LysoPE, lysophosphatidylethanolamines; PA, phosphatidic acids; PC, phosphatidylcholines; PE, phosphatidylethanolamines; PG, phosphatidylglycerols; PI, phosphatidylinositols; PlasmenylPC, plasmenyl phosphatidylcholines; PlasmenylPE, plasmenyl phosphatidylethanolamines; PS, phosphatidylserines; and SM, sphingomyelins.

Discussion

Fatty degeneration, which is commonly observed in patients with rotator cuff tears, limits functional recovery following surgical repair 3,7. The MRL mouse strain displays reduced pathological changes and improved recovery in some disease and injury states 9–13,15, but not in others 16,17. Based on these findings we hypothesized that, compared to B6 mice, MRL mice would have less muscle fiber atrophy and fat accumulation, and be protected against the loss in muscle strength that occurs after rotator cuff tear. While there were widespread differences in gene expression observed between the strains, contrary to our hypothesis we observed no improvement in relative muscle fiber force production or atrophy, and no substantial favorable changes in the metabolome or lipidome between B6 and MRL strains. The general findings from this study indicate that MRL mice are not protected from fatty degeneration after rotator cuff tear.

A pronounced loss of strength is observed in patients with rotator cuff tears 4,7,34,35. In the current study, control MRL mice had a sFo that was 52% higher than B6 mice, suggesting that muscle fibers from MRL mice have a greater density of myofibrils per cross-section at baseline. However, while MRL mice had higher sFo values, both strains experienced a 40% reduction in sFo after tear. Using the same surgical model, rats had a 50% reduction in sFo 30 days after rotator cuff tear 20. Patients with a rotator cuff tear have a 29% reduction in sFo, and sFo is negatively correlated with patient reported indices of shoulder function 4. The findings of reduced force production are consistent with the observed general reduction in contractile and muscle fiber cytoskeletal genes and alterations in muscle regenerative genes in this study, and in previous reports evaluating pathological changes in muscles after rotator cuff tear 20,25,36–38.

Fibrosis is commonly observed after rotator cuff tear 25,37,38. In the current study, there was a general upregulation in type I (Col1a1 and Col1a2) and type IV (Col4a1) collagen, elastin (Eln), as well as the proteoglycans biglycan (Bgn), thrombospondin 4 (Thsb4), tenomodulin (Tnmd), and tenascin C (Tnc) after injury. Fibroblasts synthesize and remodel the muscle ECM 39, and fibroblasts markers such as S100a4, Scx, and Tcf7l2 were upregulated and not different between B6 and MRL mice after injury. Our results therefore indicate no difference in markers of fibrosis between B6 and MRL mice after rotator cuff tear.

Changes in the metabolome and lipidome have important functional consequences in the context of rotator cuff tears. Using a rat model, we demonstrated that mitochondrial dysfunction leads to the progressive lipid accumulation that occurs after rotator cuff tear 20. We did not directly measure mitochondrial function in the current study, but gene enrichment analysis predicted mitochondrial dysfunction in both B6 and MRL groups after rotator cuff tear, and there was a downregulation in key genes involved in β-oxidation of lipids in mitochondria and aerobic metabolism. These genes include as acyl-CoA synthetases (Acads) and dehydrogenase (Acss1), carnitine palmitoyl transferases (Cpt1b and Cpt2), succinate dehydogenase (Sdha), carnitine acylcarnitine translocase (Slc25a20), and succinyl CoA synthetase (Suclg1). These findings are in agreement with observation in rats 20, but there was some divergence in glycolytic metabolism between rats, and B6 and MRL mouse muscles after rotator cuff tear. There was a marked induction in glycolytic metabolites in rats, and B6 muscles showed a similar increase in several of the same metabolites. However, MRL mice only had slight changes in glycolytic metabolites but substantial increases in several free amino acids. These findings may indicate strain-specific differences in substrate metabolism, with B6 mice relying on glycolytic metabolism, while MRL mice might shift to greater amino acid and ketone metabolism after injury. An increased reliance on amino acid metabolism in the MRL mice is supported by an elevation in histidine ammonia-lyase (Hal), which is a critical enzyme involved in histidine and glutamate metabolism 40 and is one of the most highly upregulated genes in MRL mice both before and after rotator cuff tear.

There were also differences in lipid species between B6 and MRL mice. Thirty days after rotator cuff tear, rats demonstrated an increase in triglycerides, diglycerides, FFA, CE, LysoPC, PC, PE, PG, PI, PS, and SM, with no change in monoglycerides, LysoPE, or PlasmenylPE 20. In agreement with these findings, B6 mice had an elevation in triglycerides and CE, while MRL mice had increased FFA, PC, and PE, and both strains had higher levels of LysoPC and SM. Different from rats with rotator cuff tears, B6 mice demonstrated increased LysoPE, and MRL mice had higher PlasmenylPE, with both having elevated monoglycerides. Taken together, there are strain- and species-specific changes in the metabolome and lipidome after rotator cuff tear. The differences in response between B6 and MRL mice, however, do not impact functional changes in the protection against weakness after rotator cuff tear.

Recent work identified that the transcription factor HIF1α was enriched in a muscle stem cell population in MRL mice compared B6 mice 14,15. The elevated levels of HIF1α resulted in several changes in vitro that generally correlate with improved muscle healing in vivo, including increased the expression of the myogenic transcription factor Pax7, increased cell proliferation, and an induction of cell survival and reactive oxygen species buffering genes 14,15. Increased glycolytic gene expression was also observed in cultured cells 14. Using a cardiotoxin injury model, gastrocnemius muscles of MRL mice had reduced macrophage signal intensity and fewer IgG+ fibers through 5 days after injury 15. By 30 days, MRL mice had a greater number of Pax7+ cells per myofiber, and increased dystrophin+ muscle fibers. The authors concluded that this demonstrated improved healing in the MRL mice in response to cardiotoxin, but no measures of muscle fiber size, fibrosis, or force production were measured 15. In the current study, we did not identify a difference in Hif1α expression between MRL and B6 mice, and no clear differences in metabolites indicative of a shift towards glycolytic metabolism were observed in MRL mice. There were also no appreciable differences in relative muscle fiber force production after injury. While these previous studies identified a improved in vitro properties of muscle progenitor cells and a protective role for the MRL strain in response to select measures of gastrocnemius muscle injury 14,15, while we could selectively identify some positive beneficial changes in individual gene expression or metabolites, since there was not an improvement in force production our results indicate that MRL mice are not protected from weakness and atrophy after rotator cuff tear.

There are several limitations to this study. We only included male mice, and it is possible that the MRL background would confer greater protection against fatty degeneration in female mice. We did not repair torn rotator cuffs in this study, and it is possible that there are strain-specific effects on rotator cuff healing that occur independent of the development of fatty degeneration. Due to their quadripedal gait, the mechanical loading demands of the rotator cuff of mice is different from humans. A single time point was evaluated in this study, and there could be differences between B6 and MRL mice at later time points. We only evaluated 3 month old mice, and there is known to be an aging-associated exacerbation in pathological changes in rotator cuff tears 41. To limit the number of mice used in this study and to simulate a massive rotator cuff tear, we induced a tear in both the supraspinatus and infraspinatus and used both muscles for analysis, but it is possible that changes observed in one rotator cuff muscle group are not relevant to another rotator cuff muscle group. Despite these limitations, we think this report provides important insight into the biological changes in muscle function after rotator cuff tear.

Rotator cuff tears can result in profound pain and disability that persist despite a technically successful surgical repair 1,7,42, and our ability to treat the extensive muscle atrophy and fatty degeneration that occur as a result of the tear is limited 3. While there were numerous differences in the transcriptome, metabolome, and lipidome between B6 and MRL mice, this did not lead to any functional differences in relative muscle fiber force production between strains. We therefore think it is important to include functional assays, like measuring force production, in multiomics studies. The results also further support that the fat which accumulates after rotator cuff likely occurs due to deficits in lipid oxidation, leading to a pro-inflammatory and lipotoxic state that impairs regeneration. Although the MRL background did not convey functional protection against pathological changes in muscles after rotator cuff tear, several studies have shown that MRL mice have superior tendon healing properties compared to B6 mice 11,12,43. If these findings of improved intratendon healing translate to enhanced bone-tendon insertion site healing, gaining a greater understanding of the biological pathways that convey improved tendon healing in MRL mice may lead to new therapies for rotator cuff tears, although it is not clear that these would directly impact muscle regeneration.

Supplementary Material

Supp TableS1
Supp TableS2
Supp TableS3

Acknowledgements

This work was funded by NIH grant R01-AR063649. The University of Michigan Metabolomics Core is supported by NIH grant U24-DK097153. We would like to acknowledge technical assistance from Dr. David Oliver and Mr. Damonie Salmon at the Hospital for Special Surgery.

References

  • 1.Colvin AC, Egorova N, Harrison AK, et al. 2012. National trends in rotator cuff repair. J Bone Joint Surg Am 94(3):227–233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Virk MS, Levy DM, Kuhns BD, et al. 2017. Patient Preference Before and After Arthroscopic Rotator Cuff Repair: Which Is More Important, Pain Relief or Strength Return? Am J. Orthop 46(4):E244–E250. [PubMed] [Google Scholar]
  • 3.Bedi A, Dines J, Warren RF, Dines DM. 2010. Massive tears of the rotator cuff. J Bone Joint Surg Am 92(9):1894–1908. [DOI] [PubMed] [Google Scholar]
  • 4.Mendias CL, Roche SM, Harning JA, et al. 2015. Reduced muscle fiber force production and disrupted myofibril architecture in patients with chronic rotator cuff tears. J Shoulder Elbow Surg 24(1):111–119. [DOI] [PubMed] [Google Scholar]
  • 5.Gibbons MC, Singh A, Anakwenze O, et al. 2017. Histological Evidence of Muscle Degeneration in Advanced Human Rotator Cuff Disease. J Bone Joint Surg Am 99(3):190–199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Valencia AP, Lai JK, Iyer SR, et al. 2018. Fatty Infiltration Is a Prognostic Marker of Muscle Function After Rotator Cuff Tear. Am J Sports Med 46(9):2161–2169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Gladstone JN, Bishop JY, Lo IKY, Flatow EL. 2007. Fatty infiltration and atrophy of the rotator cuff do not improve after rotator cuff repair and correlate with poor functional outcome. Am J Sports Med 35(5):719–728. [DOI] [PubMed] [Google Scholar]
  • 8.Heydemann A 2012. The super super-healing MRL mouse strain. Front Biol (Beijing) 7(6):522–538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fitzgerald J, Rich C, Burkhardt D, et al. 2008. Evidence for articular cartilage regeneration in MRL/MpJ mice. Osteoarthr Cartil 16(11):1319–1326. [DOI] [PubMed] [Google Scholar]
  • 10.Ward BD, Furman BD, Huebner JL, et al. 2008. Absence of posttraumatic arthritis following intraarticular fracture in the MRL/MpJ mouse. Arthritis Rheum 58(3):744–753. [DOI] [PubMed] [Google Scholar]
  • 11.Lalley AL, Dyment NA, Kazemi N, et al. 2015. Improved biomechanical and biological outcomes in the MRL/MpJ murine strain following a full-length patellar tendon injury. J Orthop Res 33(11):1693–1703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Paredes J, Shiovitz DA, Andarawis-Puri N. 2018. Uncorrelated healing response of tendon and ear injuries in MRL highlight a role for the local tendon environment in driving scarless healing. Connect Tissue Res 59(5):472–482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Heydemann A, Swaggart KA, Kim GH, et al. 2012. The superhealing MRL background improves muscular dystrophy. Skelet Muscle 2(1):26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sinha KM, Tseng C, Guo P, et al. 2019. Hypoxia-inducible factor 1α (HIF-1α) is a major determinant in the enhanced function of muscle-derived progenitors from MRL/MpJ mice. The FASEB Journal 33(7):8321–8334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tseng C, Sinha K, Pan H, et al. 2019. Markers of Accelerated Skeletal Muscle Regenerative Response in Murphy Roths Large Mice: Characteristics of Muscle Progenitor Cells and Circulating Factors. Stem Cells 37(3):357–367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Beare AHM, Metcalfe AD, Ferguson MWJ. 2006. Location of injury influences the mechanisms of both regeneration and repair within the MRL/MpJ mouse. J Anat 209(4):547–559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Robey TE, Murry CE. 2008. Absence of regeneration in the MRL/MpJ mouse heart following infarction or cryoinjury. Cardiovasc. Pathol. 17(1):6–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Davies MR, Ravishankar B, Laron D, et al. 2015. Rat rotator cuff muscle responds differently from hindlimb muscle to a combined tendon-nerve injury. J Orthop Res 33(7):1046–1053. [DOI] [PubMed] [Google Scholar]
  • 19.Schubert MF, Noah AC, Bedi A, et al. 2019. Reduced Myogenic and Increased Adipogenic Differentiation Capacity of Rotator Cuff Muscle Stem Cells. J Bone Joint Surg Am 101(3):228–238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Gumucio JP, Qasawa AH, Ferrara PJ, et al. 2019. Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis. The FASEB Journal 33(7):7863–7881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wada S, Lebaschi AH, Nakagawa Y, et al. 2019. Postoperative Tendon Loading With Treadmill Running Delays Tendon-to-Bone Healing: Immunohistochemical Evaluation in a Murine Rotator Cuff Repair Model. J Orthop Res 22(7):675–1637. [DOI] [PubMed] [Google Scholar]
  • 22.Davis ME, Stafford PL, Jergenson MJ, et al. 2015. Muscle Fibers are Injured at the Time of Acute and Chronic Rotator Cuff Repair. Clin Orthop Relat Res 473(1):226–232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ward SR, Sarver JJ, Eng CM, et al. 2010. Plasticity of muscle architecture after supraspinatus tears. J Orthop Sports Phys Ther 40(11):729–735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gigliotti D, Leiter JRS, Macek B, et al. 2015. Atrophy, inducible satellite cell activation, and possible denervation of supraspinatus muscle in injured human rotator-cuff muscle. AJP - Cell Physiology 309(6):C383–91. [DOI] [PubMed] [Google Scholar]
  • 25.Davis ME, Korn MA, Gumucio JP, et al. 2015. Simvastatin reduces fibrosis and protects against muscle weakness after massive rotator cuff tear. J Shoulder Elbow Surg 24(2):280–287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Roche SM, Gumucio JP, Brooks SV, et al. 2015. Measurement of Maximum Isometric Force Generated by Permeabilized Skeletal Muscle Fibers. J Visualized Experiments (100):e52695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mendias CL, Lynch EB, Gumucio JP, et al. 2015. Changes in skeletal muscle and tendon structure and function following genetic inactivation of myostatin in rats. J Physiol (Lond) 593(8):2037–2052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gumucio JP, Davis ME, Bradley JR, et al. 2012. Rotator cuff tear reduces muscle fiber specific force production and induces macrophage accumulation and autophagy. J Orthop Res 30(12):1963–1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139–140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sarver DC, Sugg KB, Disser NP, et al. 2017. Local cryotherapy minimally impacts the metabolome and transcriptome of human skeletal muscle. Sci Rep 7(1):2423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lorenz MA, Burant CF, Kennedy RT. 2011. Reducing time and increasing sensitivity in sample preparation for adherent mammalian cell metabolomics. Anal. Chem. 83(9):3406–3414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kind T, Liu K-H, Lee DY, et al. 2013. LipidBlast in silico tandem mass spectrometry database for lipid identification. Nat. Methods 10(8):755–758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Chong J, Soufan O, Li C, et al. 2018. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 46(W1):W486–W494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gerber C, Schneeberger AG, Hoppeler H, Meyer DC. 2007. Correlation of atrophy and fatty infiltration on strength and integrity of rotator cuff repairs: a study in thirteen patients. J Shoulder Elbow Surg 16(6):691–696. [DOI] [PubMed] [Google Scholar]
  • 35.Baumer TG, Chan D, Mende V, et al. 2016. Effects of Rotator Cuff Pathology and Physical Therapy on In Vivo Shoulder Motion and Clinical Outcomes in Patients With a Symptomatic Full-Thickness Rotator Cuff Tear. Orthop J Sports Med 4(9):2325967116666506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Davies MR, Liu X, Lee L, et al. 2016. TGF-β Small Molecule Inhibitor SB431542 Reduces Rotator Cuff Muscle Fibrosis and Fatty Infiltration By Promoting Fibro/Adipogenic Progenitor Apoptosis. PLoS ONE 11(5):e0155486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Killian ML, Lim CT, Thomopoulos S, et al. 2013. The effect of unloading on gene expression of healthy and injured rotator cuffs. J Orthop Res 31(8):1240–1248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wilde JM, Gumucio JP, Grekin JA, et al. 2016. Inhibition of p38 mitogen-activated protein kinase signaling reduces fibrosis and lipid accumulation after rotator cuff repair. J Shoulder Elbow Surg 25(9):1501–1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mackey AL, Magnan M, Chazaud B, Kjaer M. 2017. Human skeletal muscle fibroblasts stimulate in vitro myogenesis and in vivo muscle regeneration. J Physiol (Lond) 126(15):5610–5127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Suchi M, Sano H, Mizuno H, Wada Y. 1995. Molecular cloning and structural characterization of the human histidase gene (HAL). Genomics 29(1):98–104. [DOI] [PubMed] [Google Scholar]
  • 41.Gumucio JP, Korn MA, Saripalli AL, et al. 2014. Aging-associated exacerbation in fatty degeneration and infiltration after rotator cuff tear. J Shoulder Elbow Surg 23(1):99–108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Yamaguchi K, Ditsios K, Middleton WD, et al. 2006. The demographic and morphological features of rotator cuff disease. A comparison of asymptomatic and symptomatic shoulders. J Bone Joint Surg Am 88(8):1699–1704. [DOI] [PubMed] [Google Scholar]
  • 43.Andarawis-Puri N, Flatow EL. 2018. Promoting effective tendon healing and remodeling. J Orthop Res 36(12):3115–3124. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supp TableS1
Supp TableS2
Supp TableS3

RESOURCES